Kaken Pharmaceutical

Company Deals Drug

Johnson & Johnson Secures Licensing Deal with Kaken Pharmaceutical for STAT6 Program

Fineline Cube Dec 27, 2024

US giant Johnson & Johnson (J&J, NYSE: JNJ) has announced an exclusive licensing agreement with...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod